PL2125871T3 - Peptydy o działaniu przeciwbakteryjnym - Google Patents

Peptydy o działaniu przeciwbakteryjnym

Info

Publication number
PL2125871T3
PL2125871T3 PL08701953T PL08701953T PL2125871T3 PL 2125871 T3 PL2125871 T3 PL 2125871T3 PL 08701953 T PL08701953 T PL 08701953T PL 08701953 T PL08701953 T PL 08701953T PL 2125871 T3 PL2125871 T3 PL 2125871T3
Authority
PL
Poland
Prior art keywords
antibacterial peptides
antibacterial
peptides
Prior art date
Application number
PL08701953T
Other languages
English (en)
Inventor
Deborah O'neil
Original Assignee
Novabiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd
Publication of PL2125871T3 publication Critical patent/PL2125871T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
PL08701953T 2007-02-02 2008-01-28 Peptydy o działaniu przeciwbakteryjnym PL2125871T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89914907P 2007-02-02 2007-02-02
GBGB0702021.7A GB0702021D0 (en) 2007-02-02 2007-02-02 Peptides and their use
EP08701953.5A EP2125871B1 (en) 2007-02-02 2008-01-28 Antibacterial peptides
PCT/GB2008/000281 WO2008093058A2 (en) 2007-02-02 2008-01-28 Peptides and their use

Publications (1)

Publication Number Publication Date
PL2125871T3 true PL2125871T3 (pl) 2015-05-29

Family

ID=37891190

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08701953T PL2125871T3 (pl) 2007-02-02 2008-01-28 Peptydy o działaniu przeciwbakteryjnym

Country Status (16)

Country Link
US (1) US9371363B2 (pl)
EP (1) EP2125871B1 (pl)
JP (2) JP2010517986A (pl)
CN (1) CN101641371B (pl)
AU (1) AU2008211787B2 (pl)
CA (1) CA2706621C (pl)
DK (1) DK2125871T3 (pl)
ES (1) ES2532008T3 (pl)
GB (1) GB0702021D0 (pl)
HR (1) HRP20150195T1 (pl)
HU (1) HUE024904T2 (pl)
NZ (1) NZ578951A (pl)
PL (1) PL2125871T3 (pl)
PT (1) PT2125871E (pl)
SI (1) SI2125871T1 (pl)
WO (1) WO2008093058A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702020D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
WO2009153418A1 (fr) * 2008-06-16 2009-12-23 Centre National De La Recherche Scientifique (C.N.R.S) Peptides harp inhibant la croissance tumorale
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
GB201016733D0 (en) 2010-10-05 2010-11-17 Novabiotics Ltd Compounds and their use
GB201021186D0 (en) 2010-12-14 2011-01-26 Novabiotics Ltd Composition
CN102432672A (zh) * 2011-12-13 2012-05-02 重庆理工大学 一组新型合成抗菌肽及其应用
EP2892913A4 (en) * 2012-09-07 2017-01-18 Agency For Science, Technology And Research Peptides and their uses
GB201403268D0 (en) * 2014-02-25 2014-04-09 Univ Birmingham Antimicrobial surface
JP6464507B2 (ja) * 2014-12-24 2019-02-06 国立大学法人秋田大学 抗ウイルス剤、および抗菌剤
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
EP3434287B1 (en) * 2017-07-25 2021-01-27 Arta Peptidion S.r.l.s. Short and ultra-short antimicrobial lipopeptides and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002090503A2 (en) * 2001-05-04 2002-11-14 The Scripps Research Institute Anti-microbial peptides and compositions
ATE489462T1 (de) * 2002-04-25 2010-12-15 Toagosei Co Ltd Antimikrobielles polypeptid und nutzung davon
FR2841902A1 (fr) * 2002-07-08 2004-01-09 Diatos Peptides lineaires cationiques ayant des proprietes antibacteriennes et/ou antifongiques
US20060166867A1 (en) * 2003-04-28 2006-07-27 Yeda Research And Development Co. Ltd. Novel conjugates of polysaccharides and uses thereof
BE1015863A6 (nl) * 2004-01-19 2005-10-04 Huybrechts Lucas Anticariogene proteinen & peptiden & sacchariden.
CA2557814A1 (en) * 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
EP1927597B1 (en) * 2004-08-18 2016-11-02 Novabiotics Limited Antibacterial peptides
GB0702022D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
GB0702020D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use

Also Published As

Publication number Publication date
PT2125871E (pt) 2015-03-26
US9371363B2 (en) 2016-06-21
CA2706621C (en) 2017-12-05
WO2008093058A2 (en) 2008-08-07
JP2014012664A (ja) 2014-01-23
WO2008093058A3 (en) 2008-10-23
JP2010517986A (ja) 2010-05-27
HK1139421A1 (en) 2010-09-17
CN101641371B (zh) 2013-11-06
AU2008211787A1 (en) 2008-08-07
AU2008211787B2 (en) 2013-10-17
US20100047186A1 (en) 2010-02-25
HUE024904T2 (en) 2016-02-29
SI2125871T1 (sl) 2015-06-30
GB0702021D0 (en) 2007-03-14
CN101641371A (zh) 2010-02-03
EP2125871A2 (en) 2009-12-02
HRP20150195T1 (xx) 2015-06-05
EP2125871B1 (en) 2015-01-28
DK2125871T3 (en) 2015-03-09
ES2532008T3 (es) 2015-03-23
CA2706621A1 (en) 2008-08-07
NZ578951A (en) 2012-03-30
JP5756495B2 (ja) 2015-07-29

Similar Documents

Publication Publication Date Title
IL199835A0 (en) Novel antimicrobial peptides
GB0724349D0 (en) Antibacterial agents
EP2021364A4 (en) IMPROVED ANTIMICROBIAL PEPTIDES
PT2125871E (pt) Péptidos antibacterianos
GB0723712D0 (en) Peptides
ZA201000283B (en) Reinigung pegylierter polypeptide
GB0718735D0 (en) Antibacterial agents
EP2207193A4 (en) SWITCH
HRP20190262T1 (hr) Antimikrobni peptidi bazirani na cmap27
GB0921995D0 (en) Antimicrobial peptides
GB0920981D0 (en) Peptides
EP2123666A4 (en) PEPTIDE
GB0703945D0 (en) Peptide
TWI366853B (en) Switch
GB0920987D0 (en) Peptides
IL197675A0 (en) Peptides
GB0708529D0 (en) Peptide standards
GB0817978D0 (en) Peptides
GB0707884D0 (en) Switch
GB0705251D0 (en) Peptides
GB0707626D0 (en) Peptides
GB0705115D0 (en) Peptides
GB0718814D0 (en) Bioactive peptide
GB0810449D0 (en) Peptides
GB0815673D0 (en) Peptides